Back

Uromodulin as a genetically anchored biomarker stratifies time to valve intervention in aortic regurgitation

31 August 2026 (12:50 - 13:00)
Organised by: Logo
Congress Presentation Part of: How to predict outcomes in aortic regurgitation? Pathophysiology and Mechanisms ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Emily Ghanbari

German Heart Centre Berlin, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Sex-specific prognostic value of global longitudinal strain beyond ventricular remodeling in chronic severe aortic regurgitation
Doctor S. Lee (Seoul, KR)
Abstract
Presentation thumbnail
Non-invasive left ventricle strain-volume-pressure loops in asymptomatic patients with significant aortic regurgitation: potential to improve prediction of optimal timing for aortic valve surgery
Doctor E. de Oliveira (Aalst, BE)
Abstract
Presentation thumbnail
Prognostic impact of mild aortic regurgitation in moderate aortic stenosis: a mixed valve disease phenotype
Mr J. Iroulart (Buenos Aires, AR)
Abstract
Presentation thumbnail
Prognosis of combined moderate mitral and aortic regurgitation and isolated severe aortic regurgitation
Doctor A. Kaplan (Ramat Gan, IL)
Abstract
Presentation thumbnail
Increased left atrial pressure in chronic aortic regurgitation: association with outcomes
Mrs P. Lopez Santi (Leiden, NL)
Abstract

Access the full session

Session thumbnail
How to predict outcomes in aortic regurgitation?

The Event

Event poster

ESC Congress 2026

31 August 2026 12:50 CET
You may be interested in
thumbnail
Congress Presentation
The urinary proteomic profile of arterial stiffness in the general population
27 August 2021
thumbnail
Congress Presentation
When to treat asymptomatic severe aortic regurgitation: too early, too late, and everything in between
31 August 2024
thumbnail
Congress Presentation
Renal function as a cornerstone for risk stratification in acute heart failure
21 March 2026
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources